1,2-distearoylphosphatidylethanolamine has been researched along with Carcinoma, Hepatocellular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Dai, C; Hu, H; Lu, J; Sun, Y; Yin, M | 1 |
| Agnihotri, A; Bansal, D; Dubey, N; Ganeshpurkar, A; Pandey, V; Yadav, K | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes.
Topics: Animals; Binding Sites; Binding, Competitive; Carcinoma, Hepatocellular; Cell Death; Glycyrrhetinic Acid; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Membrane Lipids; Phosphatidylethanolamines; Polyethylene Glycols; Proton Magnetic Resonance Spectroscopy | 2018 |
Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Disaccharides; Drug Carriers; Drug Delivery Systems; Ethyldimethylaminopropyl Carbodiimide; Liposomes; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Particle Size; Phosphatidylethanolamines; Tissue Distribution | 2016 |